RBOT:NYE-Vicarious Surgical Inc. (USD)

COMMON STOCK | Medical Devices |

Last Closing

USD 5.76

Change

0.00 (0.00)%

Market Cap

USD 0.03B

Volume

9.41K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Vicarious Surgical Inc. develops and sells single-port surgical robot in the United States. It offers Vicarious Surgical System, a single-port surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. The company was founded in 2014 and is headquartered in Waltham, Massachusetts.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-29 )

Largest Industry Peers for Medical Devices

Symbol Name Price(Change) Market Cap
ABT Abbott Laboratories

N/A

USD 195.62B
MDT Medtronic PLC

N/A

USD 115.25B
STE STERIS plc

N/A

USD 23.57B
ZBH Zimmer Biomet Holdings Inc

N/A

USD 22.04B
SNN Smith & Nephew SNATS Inc

N/A

USD 13.37B
GMED Globus Medical

N/A

USD 9.55B
BIO-B Bio-Rad Laboratories Inc

N/A

USD 9.22B
BIO Bio-Rad Laboratories Inc

N/A

USD 9.22B
PEN Penumbra Inc

N/A

USD 7.80B
GKOS Glaukos Corp

N/A

USD 7.05B

ETFs Containing RBOT

XBM:CA iShares S&P/TSX Global Ba.. 9.53 % 0.62 %

N/A

CAD 0.27B
SLX VanEck Steel ETF 9.50 % 0.56 %

N/A

N/A
SCID 0.51 % 0.39 %

N/A

N/A
JPEU 0.46 % 0.40 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Medical Devices) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 1,469.48% 97% N/A 98% N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 1,469.48% 97% N/A 98% N/A
Trailing 12 Months  
Capital Gain 874.62% 97% N/A 97% N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 874.62% 97% N/A 97% N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -44.38% N/A N/A N/A F
Dividend Return -44.38% N/A N/A N/A F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 57.96% N/A N/A 15% F
Risk Adjusted Return -76.56% N/A N/A 2% F
Market Capitalization 0.03B 7% C- 15% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Underpriced compared to book value

The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector